Influenza is a viral infection that attacks the respiratory system. It can cause mild to severe illness, and at times can lead to death.
Influenza in Childhood Provides Lifelong Protection Against Flu Viruses from Animals
People born before 1968 are more susceptible to certain viruses, while people born during or after that year are more at risk for different strains of the flu.
People born before 1968 are more susceptible to certain viruses, while people born during or after that year are more at risk for different strains of the flu.
‘The antiviral drug oseltamivir can reduce influenza infections and prevent deaths in a cost-saving manner under most pandemic scenarios.’
Investigators' analyses of phase II clinical data and information
from a previous influenza outbreak revealed that oseltamivir 75 mg
relative to no treatment was effective and affordable under all
scenarios. Oseltamivir 150 mg relative to 75 mg was not cost effective
in low transmissibility scenarios but was cost saving in high
transmissibility scenarios. "We used influenza as the critical exemplar for us to test the concept that interdisciplinary pharmacometrics can be applied where the pharmacokinetics/pharmacodynamics, clinical, or epidemiological endpoints of interest can eventually be linked to health economic value" said Prof. Carl Kirkpatrick co-author of the British Journal of Clinical Pharmacology study.
"This approach - which we have called 'pharmacology to the payer' - can be applied across all disease areas and should facilitate greater dialogue between industry, regulators, payers, and patients earlier in the drug development process," added co-author Craig Rayner.
Influenza Vaccination Not Only Benefits Youth But also Protects the Elderly
A 10-year study has found that annual influenza vaccinations can also reduce the hospitalization rate and delay mortality among the elderly along with youth.
A 10-year study has found that annual influenza vaccinations can also reduce the hospitalization rate and delay mortality among the elderly along with youth.
Evidence of Host Adaptation of Avian-origin Influenza A Virus: Study
In February 2013 a novel avian-origin reassortant influenza A (H7N9) virus emerged in China and is associated with severe lower respiratory tract diseases.
In February 2013 a novel avian-origin reassortant influenza A (H7N9) virus emerged in China and is associated with severe lower respiratory tract diseases.
EU Citizens Visiting Influenza A(H7N9)-Affected Areas in China at Risk of Infection
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China.
A steep increase of human cases of avian influenza A(H7N9) has been reported since the beginning of December 2016 from China.
